According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are HK$3.09 Billion. In 2024 the company made an earning of HK$4.21 Billion, an increase over its 2023 earnings that were of HK$1.46 Billion. The earnings displayed on this page is the company's Pretax Income.